Aperio to Present at 30th Annual J.P. Morgan Healthcare Conference

| January 5, 2012

Vista, CA – January 4, 2012 - Aperio, the global leader in digital pathology solutions that improve patient care, today announced that David Schlotterbeck, chief executive officer, will present an overview of the company’s business at the 30th Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2012, at the Westin St. Francis Hotel in San Francisco. The Aperio presentation is scheduled to begin at 10:00 a.m. (PST).

During his formal presentation, Mr. Schlotterbeck will discuss the multi-billion dollar digital pathology market and highlight Aperio’s new direction in digital pathology solutions for both healthcare and life sciences. These solutions will accelerate adoption and allow pathologists to be more effective.

David_schlotterbeckDavid Schlotterbeck is the retired chairman and chief executive officer of CareFusion, a leading medical technology company. From 2004 through 2009, he served as vice chairman of Cardinal Health and chief executive officer for their clinical and medical products business segment. He joined Cardinal Health through the acquisition of Alaris Medical Systems, where he was president and chief executive officer from 1999 through 2004. Mr. Schlotterbeck previously held executive leadership roles as president and chief operating officer of Pacific Scientific Company; president and chief executive officer of Vitalcom, Inc.; and, executive vice president and chief operating officer of Nellcor, Inc. He holds a B.S. in electrical engineering from the General Motors Institute (Kettering University) and an M.S. in electrical engineering from Purdue University.

 

Sources: www.businesswire.com and www.aperio.com


Category: Digital Pathology News, Pathology News

Comments are closed.